198 related articles for article (PubMed ID: 17909820)
1. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review.
Saif MW; Hashmi S; Zelterman D; Almhanna K; Kim R
Int J Colorectal Dis; 2008 Feb; 23(2):139-45. PubMed ID: 17909820
[TBL] [Abstract][Full Text] [Related]
2. Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?
Chan AK; Wong AO; Jenken DA
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1413-9. PubMed ID: 20338475
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.
Ramani VS; Sun Myint A; Montazeri A; Wong H
Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer.
Kim JS; Kim JS; Cho MJ; Yoon WH; Song KS
J Korean Med Sci; 2006 Feb; 21(1):52-7. PubMed ID: 16479065
[TBL] [Abstract][Full Text] [Related]
6. Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.
Jootun N; Evans T; Mak J; Makin G; Platell C
ANZ J Surg; 2018 Jan; 88(1-2):62-65. PubMed ID: 28982208
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E
Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.
Yerushalmi R; Idelevich E; Dror Y; Stemmer SM; Figer A; Sulkes A; Brenner B; Loven D; Dreznik Z; Nudelman I; Shani A; Fenig E
J Surg Oncol; 2006 Jun; 93(7):529-33. PubMed ID: 16705722
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
[TBL] [Abstract][Full Text] [Related]
12. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).
Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P
J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868
[TBL] [Abstract][Full Text] [Related]
13. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
Glynne-Jones R; Dunst J; Sebag-Montefiore D
Ann Oncol; 2006 Mar; 17(3):361-71. PubMed ID: 16500912
[TBL] [Abstract][Full Text] [Related]
14. A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer.
Chen CF; Huang MY; Huang CJ; Wu CH; Yeh YS; Tsai HL; Ma CJ; Lu CY; Chang SJ; Chen MJ; Wang JY
Int J Colorectal Dis; 2012 Jun; 27(6):727-36. PubMed ID: 22258885
[TBL] [Abstract][Full Text] [Related]
15. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
[TBL] [Abstract][Full Text] [Related]
17. The role of capecitabine in locally advanced rectal cancer treatment: an update.
Fernández-Martos C; Nogué M; Cejas P; Moreno-García V; Machancoses AH; Feliu J
Drugs; 2012 May; 72(8):1057-73. PubMed ID: 22621694
[TBL] [Abstract][Full Text] [Related]
18. A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer.
Bazarbashi S; El-Bassiouni M; Abdelsalam M; Soudy H; Sanea NA; Jabbar AA; Manji M; Fagih M; Ajarim D
J Surg Oncol; 2008 Sep; 98(3):167-74. PubMed ID: 18615536
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.
Dunst J; Reese T; Sutter T; Zühlke H; Hinke A; Kölling-Schlebusch K; Frings S
J Clin Oncol; 2002 Oct; 20(19):3983-91. PubMed ID: 12351595
[TBL] [Abstract][Full Text] [Related]
20. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
